Low and fixed dose of hydroxyurea is effective and safe in patients with HbSβ+ thalassemia with IVS1‐5(G→C) mutation

E-ISSN： 1545-5017|62|6|1017-1023

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.6, 2015-06, pp. : 1017-1023

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rapid Detection of the DPYD IVS14+1G>A Mutation for Screening Patients to Prevent Fluorouracil-Related Toxicity

By Bosch Tessa M.

Molecular Diagnosis & Therapy, Vol. 11, Iss. 2, 2007-01 ,pp. : 105-108

Adis International

Access to resources Recommend Favorite

Rapid Detection of the DPYD IVS14+1G>A Mutation for Screening Patients to Prevent Fluorouracil-Related Toxicity

By Lazar Andreas Gründemann Dirk Schömig Edgar

Molecular Diagnosis & Therapy, Vol. 11, Iss. 5, 2007-01 ,pp. : 341-341

Adis International

Access to resources Recommend Favorite

A case of acute chest syndrome complicated by diffuse cerebral infarcts in an adult with HbSβ‐thalassemia+

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 9, 2015-09 ,pp. : E197-E197

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nondeletional α-Thalassemia (α2- IVS-1-116, A>G HBA2): An α2 Gene Point Mutation Detected in an African-American Female for the First Time

Acta Haematologica, Vol. 132, Iss. 1, 2013-12 ,pp. : 22-23

Karger

Access to resources Recommend Favorite

Long-Term Low-Dose Spironolactone Therapy Is Safe in Oligoanuric Hemodialysis Patients

Cardiology, Vol. 114, Iss. 1, 2009-04 ,pp. : 32-38

Karger

Access to resources Recommend Favorite